Table 1.
Prevalence of morbidity indicators measured in children and adults in two study sites of Senegal in 2016 and 2017 (number of individuals examined indicated in parentheses).
| Year | Morbidity Indicator | Children | Adults | ||
|---|---|---|---|---|---|
| Barkedji | Richard Toll | Barkedji | Richard Toll | ||
| 2016 | Hematuria | 34% (n = 203) |
62% (n = 376) |
40% (n = 105) |
75% (n = 20) |
| Anemia | 43% (n = 148) |
51% (n = 382) |
36% (n = 45) |
- | |
| Total examined 1 | N = 203 | N = 391 | N = 108 | N = 20 | |
| 2017 | Hematuria | 28% (n = 326) |
73% (n = 368) |
40% (n = 80) |
39% (n = 82) |
| Anemia | - | 54% (n = 374) |
- | 74% (n = 43) |
|
| Global score 2 | 25% (n = 297) |
65% (n = 335) |
32% (n = 19) |
41% (n = 41) |
|
| Bladder intermediate score |
21% (n = 303) |
48% (n = 335) |
16% (n = 19) |
15% (n = 41) |
|
| Upper tract intermediate score |
5% (n = 297) |
15% (n = 335) |
0% (n = 19) |
2% (n = 41) |
|
| Bladder wall calcification |
6% (n = 297) |
27% (n = 335) |
0% (n = 19) |
20% (n = 41) |
|
| Hepatomegaly | 69% (n = 109) |
89% (n = 99) |
0% (n = 2) |
100% (n = 12) |
|
| Abnormal size of the right liver lobe |
0.7% (n = 144) |
2.3% (n = 222) |
50% (n = 2) |
0% (n = 44) |
|
| Dilatation of the portal vein |
0% (n = 147) |
0% (n = 220) |
0% (n = 2) |
0% (n = 46) |
|
| Splenomegaly | 0.8% (n = 128) |
1.5% (n = 201) |
0% (n = 2) |
0% (n = 3) |
|
| Total examined 1 | N = 328 | N = 391 | N = 80 | N = 86 | |
1 The total includes individuals that were examined for at least one of the morbidity indicators. 2 The global score is the sum of the bladder and the upper tract intermediate scores.